1. Home
  2. TENX vs XELA Comparison

TENX vs XELA Comparison

Compare TENX & XELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • XELA
  • Stock Information
  • Founded
  • TENX 1967
  • XELA 2014
  • Country
  • TENX United States
  • XELA United States
  • Employees
  • TENX N/A
  • XELA N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • XELA Business Services
  • Sector
  • TENX Health Care
  • XELA Consumer Discretionary
  • Exchange
  • TENX Nasdaq
  • XELA Nasdaq
  • Market Cap
  • TENX 11.4M
  • XELA 13.8M
  • IPO Year
  • TENX N/A
  • XELA N/A
  • Fundamental
  • Price
  • TENX $3.65
  • XELA $2.08
  • Analyst Decision
  • TENX Strong Buy
  • XELA
  • Analyst Count
  • TENX 3
  • XELA 0
  • Target Price
  • TENX $23.00
  • XELA N/A
  • AVG Volume (30 Days)
  • TENX 30.4K
  • XELA 56.1K
  • Earning Date
  • TENX 11-11-2024
  • XELA 08-15-2024
  • Dividend Yield
  • TENX N/A
  • XELA N/A
  • EPS Growth
  • TENX N/A
  • XELA N/A
  • EPS
  • TENX N/A
  • XELA N/A
  • Revenue
  • TENX N/A
  • XELA $1,022,030,000.00
  • Revenue This Year
  • TENX N/A
  • XELA $20.38
  • Revenue Next Year
  • TENX N/A
  • XELA N/A
  • P/E Ratio
  • TENX N/A
  • XELA N/A
  • Revenue Growth
  • TENX N/A
  • XELA N/A
  • 52 Week Low
  • TENX $2.77
  • XELA $1.83
  • 52 Week High
  • TENX $61.20
  • XELA $4.34
  • Technical
  • Relative Strength Index (RSI)
  • TENX 54.32
  • XELA 52.00
  • Support Level
  • TENX $3.30
  • XELA $1.95
  • Resistance Level
  • TENX $3.97
  • XELA $2.17
  • Average True Range (ATR)
  • TENX 0.21
  • XELA 0.10
  • MACD
  • TENX 0.04
  • XELA 0.01
  • Stochastic Oscillator
  • TENX 55.56
  • XELA 54.39

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About XELA Exela Technologies Inc.

Exela Technologies Inc is a business process automation (BPA) leader combining industry-specific and multi-industry enterprise software and solutions. The company's BPA suite of solutions is deployed in banking, healthcare, insurance, and other industries. The company's segment includes Information and Transaction Processing Solutions (ITPS), Healthcare Solutions (HS), and Legal and Loss Prevention Services (LLPS). It generates maximum revenue from the ITPS segment.

Share on Social Networks: